Moderna
About
Moderna is a biotechnology company headquartered in Cambridge that develops medicines based on messenger RNA, or mRNA. Its mission is to deliver the greatest possible impact to people through mRNA medicines, which prompt the immune system to create the tools needed to treat or prevent disease. The company became widely known for its COVID-19 vaccine and now has a pipeline of mRNA vaccines and therapies across several therapeutic areas.
Founded in 2010, Moderna spent its early years building an mRNA technology platform and the infrastructure to speed drug discovery and early development. Its mRNA Design Studio lets scientists design, research and test mRNA within days, and an internal incubator explores new directions. The company runs multiple clinical trials, focuses on infectious and serious diseases, and points out that its mRNA medicines contain no animal products or preservatives.
What to Know
- Moderna has pledged net-zero carbon emissions in Scopes 1 and 2 by 2030 and in Scope 3 by 2045.
- Employees at its U.S. campuses receive fully subsidized green transportation.
- The company publishes an Impacting Human Health report.
- It is a member of the Kendall Square Association.
Is this your business?
Claim it to add hours, photos, a description and a spotlight story.